Recent News

• 06.11.2025 - 46th Annual Global Goldman Sachs Health Care Conference
• 06.11.2025 - 46th Annual Global Goldman Sachs Health Care Conference
• 06.02.2025 - Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
• 06.02.2025 - Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
• 06.02.2025 - Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
• 05.13.2025 - Rezdiffra 2-Year Compensated MASH Cirrhosis (F4c) Data at EASL 2025
• 05.13.2025 - Rezdiffra 2-Year Compensated MASH Cirrhosis (F4c) Data at EASL 2025
• 05.10.2025 - Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
• 05.10.2025 - Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
• 05.10.2025 - Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis

Recent Filings

• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.01.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]